Category:
Prophylactic Biological Products
CAS NO:
53714-56-0
Standard:
ChP,USP,EP,
Indications:
Mechanism of Action: Leuprorelin acts as an agonist at pituitary GnRH receptors. With continuous administration, it initially stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). However, with chronic use, it suppresses these hormones, leading to decreased testosterone in males and decreased estrogen in females.
Pharmacokinetics:
Form: Leuprorelin API is usually available as a white to off-white powder.